Intestinal Involvement Secondary to the Antiphospholipid Syndrome (APS): Clinical and Immunologic Characteristics of 97 Patients: Comparison of Classic and Catastrophic APS1

Seminars in Arthritis and Rheumatism

Volumn 36, Issue 5, 2007, Pages 287-296

  Cervera, Ricard ^a   Espinosa, Gerard ^a   Cordero, Aida ^a   Oltra, M Rosa ^a   Unzurrunzaga, Ainhoa ^a   Rossiñol, Tomeu ^a   Plaza, Joan ^a   Bucciarelli, Silvia ^a   Ramos Casals, Manuel ^a   Ingelmo, Miguel ^a   Asherson, Ronald A ^b   Font, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

antiphospholipid antibodies; antiphospholipid syndrome; intestinal ischemia; ischemic colitis; mesenteric thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ABDOMINAL PAIN; ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; INTESTINE ISCHEMIA; ISCHEMIC COLITIS; MALE; MICROTHROMBUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERNATIONAL COOPERATION; INTESTINAL DISEASES; INTESTINES; MALE; MIDDLE AGED; PUBMED;

EID: 34047138368     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2006.09.003     Document Type: Article

References (64)

1. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today 35 (2005) 185-195
2. Brandt L.J., and Boley S.J. AGA technical review on intestinal ischemia. Gastroenterology 118 (2000) 954-968
3. Kumar S., Sarr M.G., and Kamath P.S. Mesenteric venous thrombosis. N Engl J Med 345 (2001) 1683-1688
4. Levine J.S., Branch D.V., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 (2002) 752-763
5. Asherson R.A. The catastrophic antiphospholipid syndrome. J Rheumatol 19 (1992) 508-512
6. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
7. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y., Espinosa G., Petri M.A., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355
8. Von Landerberg P., Asherson R.A., and Piette J.-C. Renal, hepatic and other intraabdominal manifestations in the antiphospholipid syndrome. In: Asherson R.A., Cervera R., Piette J.-C., and Shoenfeld Y. (Eds). The Antiphospholipid Syndrome II: Autoimmune Thrombosis (2002), Elsevier Science BV, Amsterdam 189-204
9. Erkan D., Cervera R., and Asherson R.A. Catastrophic antiphospholipid syndrome. Where do we stand?. Arthritis Rheum 48 (2003) 3320
10. Asherson R.A., Cervera R., de Groot P.R., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530
11. Erkan D., Asherson R.A., Espinosa G., Cervera R., Font J., Piette J.C., et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 62 (2003) 530-533
12. Masuyama J., Umino T., Murata M., Yoshio T., Takeda A., Kuriyama M., et al. A systemic lupus erythematosus patient with multiple aseptic bone necroses, thrombosis of superior mesenteric artery and antiphospholipid antibody. Ruymachi 32 (1992) 502-507
13. Violi F., Ferro D., Vasili S., D'Angelo A., Mazzola G., Quintarelli C., et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ 309 (1994) 239-240
14. Fourcade L., Depina J.J., Debone J.M., Chouc P.Y., Aillaud M.F., Klotz F., et al. Mesenteric venous thrombosis and antiphospholipid syndrome. A propos of a case. Ann Med Interne (Paris) 146 (1995) 278-280
15. Kojima E., Naito K., Iwai M., Hirose Y., Isobe K., and Takano K. Antiphospholipid syndrome complicated by thrombosis of the superior mesenteric artery, co-existence of smooth muscle hyperplasia. Intern Med 36 (1997) 528-531
16. Lee H.J., Park J.W., and Chang J.C. Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome. J Gastroenterol Hepatol 12 (1997) 822-826
17. Kim J.H., Ha H.K., Yoon K.H., Lee Y.S., Park K.B., Lee I.J., et al. CT features of abdominal manifestation of primary antiphospholipid syndrome. J Comput Assist Tomogr 23 (1999) 678-683
18. Orth T., Mayet W.J., Wanitschke R., Hafner G., Hinkeldey K., and Galle P.R. Acute mesenterial artery occlusion-an unusual symptom of primary antiphospholipid antibody syndrome. Med Klin 95 (2000) 409-412
19. Higa M., Kojima M., Ohnuma S., Hamanaka S., Yamamuro W., Sugiura H., et al. Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome. Intern Med 40 (2001) 1245-1249
20. Kaushik S., Federls M.P., Schur P.H., Krishnan M., Silverman S.G., and Ros P.R. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology 218 (2001) 768-771
21. Jürgensen J.R., Kettritz R., Schneider W., Koop H., Hildebrand D.S., Frei U., et al. Catastrophic antiphospholipid syndrome masquerading and ischemic colitis. Rheumatol Int 23 (2003) 204-206
22. Ilkgul O., Icoz G., Dayangac M., Tokat Y., and Ozutemiz O. A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal haemorrhage. Turk J Gastroenterol 15 (2004) 115
23. Medina G., Vera-Lastra O., Barile L., Salas M., and Jara L.J. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients. Lupus 13 (2004) 11-16
24. Muñoz S., Cubo P., Gonzalez-Castillo J., Nuevo J.A., Garcia-Lamberechts E.J., and Sanz A. Superior mesenteric vein thrombosis: a retrospective study of thirteen cases. Rev Esp Enferm Dig 96 (2004) 385-394
25. Ahn E.R., Lander G., Bidot C.J., Jy W., and Ahn Y.S. Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following Rituximab therapy. Am J Hematol 78 (2005) 127-129
26. Asherson R.A., Mackworth-Young C.G., Harris E.N., Gharavi A.E., and Hughes G.R.V. Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int 5 (1985) 91-93
27. Asherson R.A., Morgan S.H., Harris E.N., Gharavi A.E., Krausz T., and Hughes G.R. Arterial occlusion causing large bowel infarction-a reflection of clotting diathesis in SLE. Clin Rheumatol 5 (1986) 102-106
28. Ordi J., Vargas V., Vilardell M., Barquinero J., and Guardia J. Lupus anticoagulant and portal hypertension. Am J Med 84 (1988) 566-567
29. Asherson R.A., Thompson R.P.H., MacLachlan N., Baguley E., Hicks P., and Hughes G.R. Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus. J Rheumatol 16 (1989) 219-223
30. Cappell M.S., and Seisbold J.R. Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus. Am J Gastroenterol 87 (1992) 520-522
31. Sanchez-Guerrero J., Reyes E., and Alarcon-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 19 (1992) 623-626
32. Martinez Vázquez C., Rivera A., Albo C., and Rueda C. Superior mesenteric vein thrombosis and primary antiphospholipid syndrome. Rev Clin Esp 192 (1993) 64-65
33. Tincani A., Bozzetti F., Tardanico R., Cerri G., Balestrieri G., Lazzari F., et al. Antiphospholipid antibodies and intestinal pathology. J Rheumatol 20 (1993) 2169-2170
34. Cappell M.S., Mikhail N., and Gujral N. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci 39 (1994) 1359-1364
35. Blanc P., Barki J., Fabre J.M., Larrey D., Domergue J., Michel H., et al. Superior mesenteric vein thrombosis associated with anticardiolipin antibody without autoimmune disease. Am J Hematol 48 (1995) 137
36. England R.J.A., Woodcock B., and Zeiderman M.R. Superior mesenteric artery thrombosis in a patient with antiphospholipid syndrome. Eur J Vasc Endovasc Surg 10 (1995) 372-373
37. Kalman D.R., Khan A., Romain P.L., and Nompleggi D.J. Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol 91 (1996) 1244-1247
38. Gül A., Inanç M., Öcal L., Konice M., Aral O., and Lie J.T. Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease. Clin Rheumatol 15 (1996) 207-210
39. Labarca J.A., Rabaggliati R.M., Radrigan F.J., Rojas P.P., Perez C.M., Ferres M.V., et al. Antiphospholipid syndrome associated with cytomegalovirus infectious: case report and review. Clin Infect Dis 24 (1997) 197-200
40. Geelkerken R.H., Cannegieter S.C., Bouter H., and van Bockel J.H. Acute splanchnic venous thrombosis: surgical and medical treatment with special emphasis on new aspects of coagulation disorders. Eur J Vasc Endovasc Surg 13 (1997) 227-232
41. Vahl A.C., Gans R.O.B., Mackaay A.J.C., van der Waal C., and Rauwerda J.A. Superior mesenteric artery occlusion and peripheral emboli caused by an aortic ulcer in a young patient with antiphospholipid syndrome. Surgery 121 (1997) 588-590
42. Sanchez-Ortiz R.F., Fraker D.L., and Malkovicz S.B. Renal cell carcinoma presenting with mesenteric thrombosis and anticardiolipin antibodies: echoes of Trousseau′s syndrome?. J Urol 159 (1998) 2078-2080
43. Balian A., Veyradier A., Naveau S., Wolf M., Montembault S., Giraud V., et al. Prothrombin 20210G/A mutation in two patients with mesenteric ischemia. Dig Dis Sci 44 (1999) 1910-1913
44. Hamilton M.E. Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. West J Med 155 (1999) 174-176
45. Friederich P, Putensen C, Stüber F. Prothombin gene G20210A mutation and elevated anticardiolipin antibodies in a patient with portal-mesenteric vein thrombosis. Int Care Med 200,26:1571-4.
46. Patel Y.I., St John A., and McHugh N.J. Antiphospholipid syndrome with proliferative vasculopathy and bowel infarction. Rheumatology 39 (2000) 108-110
47. Soulier K., Delèvaux I., André M., Du L.T.H., Dupond J.L., Piette J.C., et al. Mesenteric venous thrombosis: early diagnosis with abdominal CT scan and interest of screening for thrombofilia. Rev Med Interne 22 (2001) 699-705
48. Mera Valera A., Blanco Rodríguez J., Insua Vilariño S., and Camaño Freire M. Systemic lupus erythematosus with retractil mesenteritis and catastrophic antiphospholipid syndrome. Ann Med Interne (Paris) 18 (2001) 143-146
49. Aranguren A., Pérez-Salazar M., Paramo J.A., Zozaya J., and Rocha E. Antiphospholipid antibodies, portal and mesenteric thrombosis and carcinoid tumor: a case report. Thromb Haemost 86 (2001) 1334
50. Chandra S., Dutta U., Das R., Vaiphei K., Nagi B., and Singh K. Mesenteric venous thrombosis causing jejunal stricture. Dig Dis Sci 47 (2002) 2017-2019
51. Choi B.G., Jeon H.S., Lee S.O., Yoo W.H., Lee S.T., and Ahn D.S. Primary antiphospholipid syndrome presenting with abdominal angina and esplenic infarction. Rheumatol Int 22 (2002) 119-121
52. Fried M., van Ganse W., and van Avermaet S. Mesenteric vein thrombosis triggered by blunt abdominal trauma in a patient with the primary antiphospholipid syndrome. Eur J Gastroenterol Hepatol 14 (2002) 697-700
53. Martinez Rubio M.P., Moreno López R., Lama M., and Sanchez Bielsa F. Primary antiphospholipid syndrome diagnosed in haemodyalisis. Nefrolog 22 (2002) 71-74
54. Güvenç B.H., Sarper N., Tuzlaci A., and Gunaltay N. Transient antiphospholipid syndrome in an infant with segmental small bowel infarction. J Pediatr Surg 39 (2004) 124-127
55. Zhang L., Hollensead S., and Parker J.C. Extensive aortic thromboembolism due to acquired hypercoagulable state. Arch Pathol Lab Med 129 (2005) 247-250
56. Cervera R., Piette J.C., Font J., Khamashta M.A., Shoenfeld Y., Camp M.T., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 (2002) 1019
57. Lock G. Acute intestinal ischaemia. Best Pract Res Clin Gastroenterol 15 (2001) 83-98
58. Oldenburg W.A., Lau L.L., Rodenberg T.J., Edmonds H.J., and Burger C.D. Acute mesenteric ischemia. A clinical review. Arch Intern Med 164 (2004) 1054-1062
59. Bucciarelli S., Espinosa G., Cervera R., Erkan D., Gomez-Puerta J.A., Ramos-Casals M., et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in 250 patients. Arthritis Rheum 54 (2006) 2568-2576
60. Meroni P.L., Raschi E., Camera M., Testoni C., Nicoletti F., Tincani A., et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 15 (2000) 237-240
61. Asherson R.A., and Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis 62 (2003) 388-393
62. Grotz M.R., Deitch E.A., Ding J., Xu D., Huang Q., and Regel G. Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 229 (1999) 478-486
63. Holland J., Carey M., Hughes N., Sweeney K., Byrne P.J., Healy M., et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis. Am J Surg 190 (2005) 393-400
64. Lockshin M.D., and Erkan D. Treatment of the antiphospholipid syndrome. N Engl J Med 349 (2003) 1177-1179